FDAnews Drug Daily Bulletin

THE IMMUNE RESPONSE CORPORATION ANNOUNCES $4.1 MILLION ALREADY RECEIVED FROM EXERCISE OF WARRANTS FROM MARCH 2006 PRIVATE PLACEMENT FINANCING

June 15, 2006
A A

The Immune Response Corporation announced that its Registration Statement for the resale of common stock underlying the convertible notes and warrants issued in the Company's March 2006 private placement financing was declared effective today by the Securities and Exchange Commission. Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060613006101&newsLang=en)